{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:55:06Z","timestamp":1788357306577,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s11060-025-05057-2","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T14:38:09Z","timestamp":1747060689000},"page":"483-492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prognostic value of MIB-1 index in meningioma: a retrospective cohort study to establish an optimal cutoff for recurrence and survival"],"prefix":"10.1007","volume":"174","author":[{"given":"Ishav Y.","family":"Shukla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ebada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Bever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Traylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingchun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darsh","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel L.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew Z.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"5057_CR1","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.2217\/fon-2018-0006","volume":"14","author":"RA Buerki","year":"2018","unstructured":"Buerki RA, Horbinski CM, Kruser T, Horowitz PM, James CD, Lukas RV (2018) An overview of meningiomas. Future Oncol 14:2161\u20132177. https:\/\/doi.org\/10.2217\/fon-2018-0006","journal-title":"Future Oncol"},{"key":"5057_CR2","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","volume":"23","author":"R Goldbrunner","year":"2021","unstructured":"Goldbrunner R, Stavrinou P, Jenkinson MD, Sahm F, Mawrin C, Weber DC, Preusser M, Minniti G, Lund-Johansen M, Lefranc F, Houdart E, Sallabanda K, Le Rhun E, Nieuwenhuizen D, Tabatabai G, Soffietti R, Weller M (2021) EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol 23:1821\u20131834. https:\/\/doi.org\/10.1093\/neuonc\/noab150","journal-title":"Neuro Oncol"},{"key":"5057_CR3","doi-asserted-by":"publisher","first-page":"Cns72","DOI":"10.2217\/cns-2021-0003","volume":"10","author":"I Maggio","year":"2021","unstructured":"Maggio I, Franceschi E, Tosoni A, Nunno VD, Gatto L, Lodi R, Brandes AA (2021) Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas. CNS Oncol 10:Cns72. https:\/\/doi.org\/10.2217\/cns-2021-0003","journal-title":"CNS Oncol"},{"key":"5057_CR4","doi-asserted-by":"publisher","unstructured":"Fogh SE, Johnson DR, Barker FG 2nd, Brastianos PK, Clarke JL, Kaufmann TJ, Oberndorfer S, Preusser M, Raghunathan A, Santagata S, Theodosopoulos PV (2016) Case-Based review: meningioma. Neurooncol Pract 3:120\u2013134. https:\/\/doi.org\/10.1093\/nop\/npv063","DOI":"10.1093\/nop\/npv063"},{"key":"5057_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s11060-022-04228-9","volume":"161","author":"MP Nasrallah","year":"2023","unstructured":"Nasrallah MP, Aldape KD (2023) Molecular classification and grading of meningioma. J Neurooncol 161:373\u2013381. https:\/\/doi.org\/10.1007\/s11060-022-04228-9","journal-title":"J Neurooncol"},{"key":"5057_CR6","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.prp.2010.09.002","volume":"206","author":"E Abry","year":"2010","unstructured":"Abry E, Thomassen I, Salvesen \u00d8O, Torp SH (2010) The significance of Ki-67\/MIB-1 labeling index in human meningiomas: a literature study. Pathol Res Pract 206:810\u2013815. https:\/\/doi.org\/10.1016\/j.prp.2010.09.002","journal-title":"Pathol Res Pract"},{"key":"5057_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","volume":"597","author":"F Nassiri","year":"2021","unstructured":"Nassiri F, Liu J, Patil V, Mamatjan Y, Wang JZ, Hugh-White R, Macklin AM, Khan S, Singh O, Karimi S, Corona RI, Liu LY, Chen CY, Chakravarthy A, Wei Q, Mehani B, Suppiah S, Gao A, Workewych AM, Tabatabai G, Boutros PC, Bader GD, de Carvalho DD, Kislinger T, Aldape K, Zadeh G (2021) A clinically applicable integrative molecular classification of meningiomas. Nature 597:119\u2013125. https:\/\/doi.org\/10.1038\/s41586-021-03850-3","journal-title":"Nature"},{"key":"5057_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/jnen\/61.3.215","volume":"61","author":"P Kleihues","year":"2002","unstructured":"Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215\u2013225 discussion 226\u2013\u2009219. https:\/\/doi.org\/10.1093\/jnen\/61.3.215","journal-title":"J Neuropathol Exp Neurol"},{"key":"5057_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3171\/2014.7.Jns131644","volume":"122","author":"L Rogers","year":"2015","unstructured":"Rogers L, Barani I, Chamberlain M, Kaley TJ, McDermott M, Raizer J, Schiff D, Weber DC, Wen PY, Vogelbaum MA (2015) Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg 122:4\u201323. https:\/\/doi.org\/10.3171\/2014.7.Jns131644","journal-title":"J Neurosurg"},{"key":"5057_CR10","doi-asserted-by":"publisher","first-page":"e0303337","DOI":"10.1371\/journal.pone.0303337","volume":"19","author":"TM Aung","year":"2024","unstructured":"Aung TM, Ngamjarus C, Proungvitaya T, Saengboonmee C, Proungvitaya S (2024) Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis. PLoS ONE 19:e0303337. https:\/\/doi.org\/10.1371\/journal.pone.0303337","journal-title":"PLoS ONE"},{"key":"5057_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/coc.0000000000000224","volume":"41","author":"Y Choi","year":"2018","unstructured":"Choi Y, Lim DH, Yu JI, Jo K, Nam DH, Seol HJ, Lee JI, Kong DS, Suh YL, Nam H (2018) Prognostic value of Ki-67 labeling index and postoperative radiotherapy in WHO grade II meningioma. Am J Clin Oncol 41:18\u201323. https:\/\/doi.org\/10.1097\/coc.0000000000000224","journal-title":"Am J Clin Oncol"},{"key":"5057_CR12","doi-asserted-by":"publisher","first-page":"480","DOI":"10.4149\/neo_2013_062","volume":"60","author":"S Pavelin","year":"2013","unstructured":"Pavelin S, Becic K, Forempoher G, Mrklic I, Pogorelic Z, Titlic M, Andelinovic S (2013) Expression of Ki-67 and p53 in meningiomas. Neoplasma 60:480\u2013485. https:\/\/doi.org\/10.4149\/neo_2013_062","journal-title":"Neoplasma"},{"key":"5057_CR13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3171\/2022.6.JNS221162","volume":"138","author":"JI Traylor","year":"2023","unstructured":"Traylor JI, Plitt AR, Hicks WH, Mian TM, Mickey BE, Barnett SL (2023) Evaluating risk of recurrence in patients with meningioma. J Neurosurg 138:621\u2013628. https:\/\/doi.org\/10.3171\/2022.6.JNS221162","journal-title":"J Neurosurg"},{"key":"5057_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/s0039-6060(96)80283-2","volume":"120","author":"JW Moul","year":"1996","unstructured":"Moul JW, Bettencourt MC, Sesterhenn IA, Mostofi FK, McLeod DG, Srivastava S, Bauer JJ (1996) Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer. Surgery 120:159\u2013166 discussion 166\u2013\u2009157. https:\/\/doi.org\/10.1016\/s0039-6060(96)80283-2","journal-title":"Surgery"},{"key":"5057_CR15","doi-asserted-by":"publisher","unstructured":"Sun X, Bizhanova A, Matheson TD, Yu J, Zhu LJ, Kaufman PD (2017) Ki-67 contributes to normal cell cycle progression and inactive X heterochromatin in p21 Checkpoint-Proficient human cells. Mol Cell Biol 37. https:\/\/doi.org\/10.1128\/mcb.00569-16","DOI":"10.1128\/mcb.00569-16"},{"key":"5057_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/path.1711680404","volume":"168","author":"G Cattoretti","year":"1992","unstructured":"Cattoretti G, Becker MH, Key G, Duchrow M, Schl\u00fcter C, Galle J, Gerdes J (1992) Monoclonal antibodies against Recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357\u2013363. https:\/\/doi.org\/10.1002\/path.1711680404","journal-title":"J Pathol"},{"key":"5057_CR17","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1186\/s12885-022-09557-6","volume":"22","author":"J Brown","year":"2022","unstructured":"Brown J, Scardo S, Method M, Schlauch D, Misch A, Picard S, Hamilton E, Jones S, Burris H, Spigel D (2022) A real-world retrospective study of the use of Ki-67 testing and treatment patterns in patients with HR+, HER2- early breast cancer in the united States. BMC Cancer 22:502. https:\/\/doi.org\/10.1186\/s12885-022-09557-6","journal-title":"BMC Cancer"},{"key":"5057_CR18","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41598-023-27684-3","volume":"13","author":"H Lindfors","year":"2023","unstructured":"Lindfors H, Karlsen M, Karlton E, Zedenius J, Larsson C, Ihre Lundgren C, Juhlin CC, Shabo I (2023) Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer. Sci Rep 13:1070. https:\/\/doi.org\/10.1038\/s41598-023-27684-3","journal-title":"Sci Rep"},{"key":"5057_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1227\/neu.0000000000001020","volume":"78","author":"M Jaber","year":"2016","unstructured":"Jaber M, W\u00f6lfer J, Ewelt C, Holling M, Hasselblatt M, Niederstadt T, Zoubi T, Weckesser M, Stummer W (2016) The value of 5-Aminolevulinic acid in Low-grade gliomas and High-grade gliomas lacking glioblastoma imaging features: an analysis based on fluorescence, magnetic resonance imaging, 18F-Fluoroethyl tyrosine positron emission tomography, and tumor molecular factors. Neurosurgery 78:401\u2013411 discussion 411. https:\/\/doi.org\/10.1227\/neu.0000000000001020","journal-title":"Neurosurgery"},{"key":"5057_CR20","first-page":"170","volume":"24","author":"SH Torp","year":"2005","unstructured":"Torp SH, Lindboe CF, Gr\u00f8nberg BH, Lydersen S, Sundstr\u00f8m S (2005) Prognostic significance of Ki-67\/MIB-1 proliferation index in meningiomas. Clin Neuropathol 24:170\u2013174","journal-title":"Clin Neuropathol"},{"key":"5057_CR21","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.3171\/2010.11.JNS10701","volume":"114","author":"S Ohba","year":"2011","unstructured":"Ohba S, Kobayashi M, Horiguchi T, Onozuka S, Yoshida K, Ohira T, Kawase T (2011) Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas: clinical Article. J Neurosurg JNS 114:1278\u20131287. https:\/\/doi.org\/10.3171\/2010.11.JNS10701","journal-title":"J Neurosurg JNS"},{"key":"5057_CR22","doi-asserted-by":"publisher","unstructured":"Lampmann T, Wach J, Schmitz MT, G\u00fcresir \u00c1, Vatter H, G\u00fcresir E (2022) Predictive power of MIB-1 vs. Mitotic count on Progression-Free survival in Skull-Base meningioma. Cancers (Basel) 14. https:\/\/doi.org\/10.3390\/cancers14194597","DOI":"10.3390\/cancers14194597"},{"key":"5057_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1227\/01.Neu.0000310692.80289.28","volume":"63","author":"AP Morokoff","year":"2008","unstructured":"Morokoff AP, Zauberman J, Black PM (2008) Surgery for convexity meningiomas. Neurosurgery 63:427\u2013433 discussion 433\u2013\u2009424. https:\/\/doi.org\/10.1227\/01.Neu.0000310692.80289.28","journal-title":"Neurosurgery"},{"key":"5057_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/neuonc\/noy137","volume":"21","author":"RY Huang","year":"2018","unstructured":"Huang RY, Bi WL, Weller M, Kaley T, Blakeley J, Dunn I, Galanis E, Preusser M, McDermott M, Rogers L, Raizer J, Schiff D, Soffietti R, Tonn J-C, Vogelbaum M, Weber D, Reardon DA, Wen PY (2018) Proposed response assessment and endpoints for meningioma clinical trials: report from the response assessment in Neuro-Oncology working group. Neurooncology 21:26\u201336. https:\/\/doi.org\/10.1093\/neuonc\/noy137","journal-title":"Neurooncology"},{"key":"5057_CR25","doi-asserted-by":"publisher","first-page":"e853","DOI":"10.1016\/S2589-7500(22)00188-1","volume":"4","author":"AAH de Hond","year":"2022","unstructured":"de Hond AAH, Steyerberg EW, van Calster B (2022) Interpreting area under the receiver operating characteristic curve. Lancet Digit Health 4:e853\u2013e855. https:\/\/doi.org\/10.1016\/S2589-7500(22)00188-1","journal-title":"Lancet Digit Health"},{"key":"5057_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jocn.2021.01.009","volume":"86","author":"R Prat-Ac\u00edn","year":"2021","unstructured":"Prat-Ac\u00edn R, Guar\u00edn-Corredor MJ, Galeano-Senabre I, Ayuso-Sacido A, Vera-Sempere F (2021) Value of KI-67\/MIB-1 labeling index and Simpson grading system to predict the recurrence of who grade I intracranial meningiomas compared to who grade II. J Clin Neurosci 86:32\u201337. https:\/\/doi.org\/10.1016\/j.jocn.2021.01.009","journal-title":"J Clin Neurosci"},{"key":"5057_CR27","doi-asserted-by":"publisher","first-page":"e18644","DOI":"10.1097\/md.0000000000018644","volume":"99","author":"N Liu","year":"2020","unstructured":"Liu N, Song SY, Jiang JB, Wang TJ, Yan CX (2020) The prognostic role of Ki-67\/MIB-1 in meningioma: A systematic review with meta-analysis. Med (Baltim) 99:e18644. https:\/\/doi.org\/10.1097\/md.0000000000018644","journal-title":"Med (Baltim)"},{"key":"5057_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4103\/jnrp.jnrp_374_18","volume":"10","author":"SS Krishnan","year":"2019","unstructured":"Krishnan SS, Muthiah S, Rao S, Salem SS, Madabhushi VC, Mahadevan A (2019) Mindbomb Homolog-1 index in the prognosis of High-Grade glioma and its clinicopathological correlation. J Neurosci Rural Pract 10:185\u2013193. https:\/\/doi.org\/10.4103\/jnrp.jnrp_374_18","journal-title":"J Neurosci Rural Pract"},{"key":"5057_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11102-010-0242-7","volume":"13","author":"G Chacko","year":"2010","unstructured":"Chacko G, Chacko AG, Kovacs K, Scheithauer BW, Mani S, Muliyil JP, Seshadri MS (2010) The clinical significance of MIB-1 labeling index in pituitary adenomas. Pituitary 13:337\u2013344. https:\/\/doi.org\/10.1007\/s11102-010-0242-7","journal-title":"Pituitary"},{"key":"5057_CR30","doi-asserted-by":"publisher","first-page":"543","DOI":"10.21037\/tlcr.2016.10.11","volume":"5","author":"M Kriegsmann","year":"2016","unstructured":"Kriegsmann M, Warth A (2016) What is better\/reliable, mitosis counting or Ki67\/MIB1 staining? Transl Lung Cancer Res 5:543\u2013546. https:\/\/doi.org\/10.21037\/tlcr.2016.10.11","journal-title":"Transl Lung Cancer Res"},{"key":"5057_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11060-021-03790-y","volume":"153","author":"WC Newman","year":"2021","unstructured":"Newman WC, Goldberg J, Guadix SW, Brown S, Reiner AS, Panageas K, Beal K, Brennan CW, Tabar V, Young RJ, Moss NS (2021) The effect of surgery on radiation necrosis in irradiated brain metastases: extent of resection and long-term clinical and radiographic outcomes. J Neurooncol 153:507\u2013518. https:\/\/doi.org\/10.1007\/s11060-021-03790-y","journal-title":"J Neurooncol"},{"key":"5057_CR32","doi-asserted-by":"publisher","first-page":"i18","DOI":"10.1093\/neuonc\/noy136","volume":"21","author":"PK Brastianos","year":"2019","unstructured":"Brastianos PK, Galanis E, Butowski N, Chan JW, Dunn IF, Goldbrunner R, Herold-Mende C, Ippen FM, Mawrin C, McDermott MW, Sloan A, Snyder J, Tabatabai G, Tatagiba M, Tonn JC, Wen PY, Aldape K, Nassiri F, Zadeh G, Jenkinson MD, Raleigh DR, Meningiomas ICo (2019) Advances in multidisciplinary therapy for meningiomas. Neurooncology 21:i18\u2013i31. https:\/\/doi.org\/10.1093\/neuonc\/noy136","journal-title":"Neurooncology"},{"key":"5057_CR33","doi-asserted-by":"publisher","first-page":"787962","DOI":"10.3389\/fonc.2021.787962","volume":"11","author":"D Song","year":"2021","unstructured":"Song D, Xu D, Han H, Gao Q, Zhang M, Wang F, Wang G, Guo F (2021) Postoperative adjuvant radiotherapy in atypical meningioma patients: A Meta-Analysis study. Front Oncol 11:787962. https:\/\/doi.org\/10.3389\/fonc.2021.787962","journal-title":"Front Oncol"},{"key":"5057_CR34","unstructured":"National Guideline A (2018) NICE Evidence Reviews Collection. Evidence reviews for the investigation, management and follow-up of meningioma: Brain tumours (primary) and brain metastases in adults: Evidence Report B. National Institute for Health and Care Excellence (NICE) Copyright \u00a9 NICE 2018., London"},{"key":"5057_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/nop\/npae117","author":"B Owusu-Adjei","year":"2024","unstructured":"Owusu-Adjei B, Lim JC, Hou CC, Mietus CJ, Daci R, Lambert W, Qureshi H, Berry BC, Marasco MRB, Paul U, Sirianni RW, Johnson MD (2024) An evidence-based framework for postoperative surveillance of meningioma. Neuro-Oncology Pract. https:\/\/doi.org\/10.1093\/nop\/npae117","journal-title":"Neuro-Oncology Pract"},{"key":"5057_CR36","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/neuonc\/noy104","volume":"20","author":"S Spiegl-Kreinecker","year":"2018","unstructured":"Spiegl-Kreinecker S, L\u00f6tsch D, Neumayer K, Kastler L, Gojo J, Pirker C, Pichler J, Weis S, Kumar R, Webersinke G, Gruber A, Berger W (2018) TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma. Neuro Oncol 20:1584\u20131593. https:\/\/doi.org\/10.1093\/neuonc\/noy104","journal-title":"Neuro Oncol"},{"key":"5057_CR37","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-020-02188-w","volume":"140","author":"P Sievers","year":"2020","unstructured":"Sievers P, Hielscher T, Schrimpf D, Stichel D, Reuss DE, Berghoff AS, Neidert MC, Wirsching HG, Mawrin C, Ketter R, Paulus W, Reifenberger G, Lamszus K, Westphal M, Etminan N, Ratliff M, Herold-Mende C, Pfister SM, Jones DTW, Weller M, Harter PN, Wick W, Preusser M, von Deimling A, Sahm F (2020) CDKN2A\/B homozygous deletion is associated with early recurrence in meningiomas. Acta Neuropathol 140:409\u2013413. https:\/\/doi.org\/10.1007\/s00401-020-02188-w","journal-title":"Acta Neuropathol"},{"key":"5057_CR38","doi-asserted-by":"publisher","unstructured":"Ogasawara C, Philbrick BD, Adamson DC (2021) Meningioma: A review of epidemiology, pathology, diagnosis, treatment, and future directions. Biomedicines 9. https:\/\/doi.org\/10.3390\/biomedicines9030319","DOI":"10.3390\/biomedicines9030319"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05057-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05057-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05057-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T11:55:31Z","timestamp":1751284531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05057-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["5057"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05057-2","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was written in compliance with our institutional ethical review board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB compliance statement and ethical adherence"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}